High Cholesterol: The Evidence-Based Supplement Protocol

6 min read ·

Statins remain the most effective LDL-lowering intervention with the strongest cardiovascular outcome data. Supplements have a defined role in adults with mildly elevated LDL who don't yet meet treatment thresholds, in statin-intolerant patients, and as adjuncts to statins for additional LDL reduction. Five supplements have FDA/EFSA health claims or strong RCT evidence: psyllium, plant sterols, oat beta-glucan, bergamot, and red yeast rice (with critical caveats).

Psyllium Husk, 10 g Daily

Psyllium has an FDA-authorized health claim for cholesterol reduction. A 2018 meta-analysis of 28 RCTs found 10 g daily reduces LDL by ~7% and total cholesterol by ~6% over 8+ weeks. Effect is independent of dietary changes. See our psyllium piece.

Plant Sterols (Beta-Sitosterol Complex), 2 g Daily

Plant sterols compete with cholesterol for intestinal absorption. The European Atherosclerosis Society endorses 2 g daily for LDL reduction of ~8–10%. Best taken with the largest meal of the day. See our beta-sitosterol piece.

Oat Beta-Glucan, 3 g Daily

Oat beta-glucan has an FDA-authorized health claim. 3 g daily reduces LDL by ~5–7% via bile-acid binding. Take from oat bran or standalone beta-glucan; rolled oats contain about 1 g per 40 g serving. See our oat beta-glucan piece.

Bergamot Citrus Polyphenol Extract, 500–1,000 mg Daily

Bergamot polyphenol fraction (BPF) is the most-studied citrus flavonoid for lipids. Pooled trial data shows LDL reductions of 15–25% at 500–1,000 mg daily over 12 weeks. The strongest single-supplement LDL signal outside red yeast rice. See our bergamot piece.

Red Yeast Rice — Pharmaceutically Active, Use Carefully

Red yeast rice contains monacolin K — the same molecule as prescription lovastatin. Effective doses reduce LDL by 15–25%. The catch: it is an unregulated low-potency statin with all the same side effects (myopathy, hepatic transaminitis) and serious supply-quality issues. Banned in some EU markets. If used, treat as a statin: get baseline LFTs, monitor for myalgia, take CoQ10 alongside, and avoid combining with prescription statins. See our red yeast rice piece.

What NOT to Take

Niacin's CVD outcome data is poor (AIM-HIGH, HPS2-THRIVE both null) despite LDL-lowering effects. Skip "lipid support" megaformulas with subclinical doses. Avoid policosanol — large independent trials are null. Avoid garlic supplements as a primary LDL intervention — too small to matter. Don't replace statin therapy in patients with established ASCVD or LDL ≥190 mg/dL.

How to Run the Protocol

Get baseline lipid panel + ASCVD risk calculator. For ASCVD risk <7.5% with LDL 100–160, lifestyle + supplements first: psyllium 10 g + plant sterols 2 g + oat beta-glucan 3 g daily for 12 weeks. Re-test. Layer bergamot 1,000 mg if additional reduction needed. Red yeast rice is a step beyond — treat as a statin substitute, not just another supplement. For risk ≥7.5%, statin therapy is the standard. See the heart health stack.

Sources

  1. Jovanovski E, Yashpal S, Komishon A, et al. "Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B." American Journal of Clinical Nutrition, 2018;108(5):922-932. PMID: 30239559. DOI: 10.1093/ajcn/nqy115.
  2. Gylling H, Plat J, Turley S, et al. "Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease." Atherosclerosis, 2014;232(2):346-360. PMID: 24468148. DOI: 10.1016/j.atherosclerosis.2013.11.043.
  3. Whitehead A, Beck EJ, Tosh S, Wolever TM. "Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials." American Journal of Clinical Nutrition, 2014;100(6):1413-1421. PMID: 25411276. DOI: 10.3945/ajcn.114.086108.
  4. Mollace V, Sacco I, Janda E, et al. "Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies." Fitoterapia, 2011;82(3):309-316. PMID: 21056640. DOI: 10.1016/j.fitote.2010.10.014.
  5. Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. "Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial." Annals of Internal Medicine, 2009;150(12):830-839. PMID: 19528562. DOI: 10.7326/0003-4819-150-12-200906160-00006.